Skip to main content

Laboratory Biosafety Guidance Related to Coronavirus Disease (COVID-19): Interim Guidance, 28 January 2021

Submitted by rileyta on February 1, 2021 - 04:14 PM

This document provides guidance on laboratory biosafety related to SARS-CoV-2 virus. Laboratories and stakeholders involved in COVID-19, to include packaging and shipping of specimens use this resource to learn more about biosafety updates for COVID-19. This update (28 January 2021) includes the following addition and revision: - biosafety aspects for working with antigen-detecting rapid diagnostic test; - handling new variants of SARS-CoV-2 in the laboratory; - updated assay decontamination before disposal; - personal protective equipment (PPE) for specimen collection; -addressing chemical hazards and their safe disposal; and - the fourth edition of the WHO Laboratory Biosafety Manual (LBM4) is now available and the terminology in this guidance was aligned with the LBM4. For more biosafety information, please refer to the World Health Organization (WHO) Laboratory Biosafety Manual (LBM4) suite found here:


World Health Organization (WHO)


World Health Organization (WHO)